Literature DB >> 26862331

Drug-induced mitochondrial impairment in liver cells.

Regina Stöber1.   

Abstract

Entities:  

Year:  2015        PMID: 26862331      PMCID: PMC4743473          DOI: 10.17179/excli2015-764

Source DB:  PubMed          Journal:  EXCLI J        ISSN: 1611-2156            Impact factor:   4.068


× No keyword cloud information.

Recently, Laia Tolosa and colleagues from Valencia University have published a study how to identify compounds that cause hepatotoxicity due to compromising mitochondrial functions (Tolosa et al., 2015[23]). The authors used a set of fluorescent probes for imaging: HepG2 cells were loaded with Hoechst 33342 for cell number determination, cell viability was determined with propidium iodid and Mitotracker Green FM was applied for quantification of mitochondrial mass (Tolosa et al., 2015[23]). For a more detailed analysis of compromised mitochondria, the authors used Fluo-4 AM to detect changes in cytoplasmic free calcium, Mitotracker Deep Red for analysis of mitochondrial localization, MitoSOX Red to analyze generation of superoxide by mitochondria, TMRM to study mitochondrial membrane potential and YO-PRO-1 for detection of apoptotic cells. Using this set of markers and quantitative imaging techniques the authors classified a set of well-known mitochondrial hepatotoxicants with excellent accuracy (Tolosa et al., 2015[23]). Drug or chemically induced liver injury represents a cutting-edge topic in toxicology (Benet et al., 2014[1]; Campos et al., 2014[2]; Vitins et al., 2014[25]; Liu et al., 2014[16]; Godoy and Bolt, 2012[6]; Vinken et al., 2012[24]; Liang et al., 2011[15]; Hammad et al., 2011[11]). Numerous research projects aim at establishing in vitro systems to predict human hepatotoxicity (Chen et al., 2014[4]; Grinberg et al., 2014[10]; Carvalho et al., 2004[3]; O'Brien et al., 2006[17]; Reif, 2015[19]; Shinde et al., 2015[21][22]; Kim et al., 2015[14]; Pfeiffer et al., 2015[18]). One of the limitations of current research is that it still remains challenging to predict doses that are associated with an increased risk of hepatotoxicity in vivo (Ghallab, 2013[5]; Reif, 2014[20]). Moreover, cultivated cells undergo major changes compared to hepatocytes in an intact liver (Godoy et al., 2015[9], 2013[8], 2009[7]; Zellmer et al., 2010[26]; Hewitt et al., 2007[13]; Hengstler et al., 2000[12]). Despite of the still remaining challenges the high-content screening platform established by Tolosa and colleagues represents an important milestone.
  25 in total

1.  Screening of repeated dose toxicity data present in SCC(NF)P/SCCS safety evaluations of cosmetic ingredients.

Authors:  Mathieu Vinken; Marleen Pauwels; Gamze Ates; Manon Vivier; Tamara Vanhaecke; Vera Rogiers
Journal:  Arch Toxicol       Date:  2011-10-29       Impact factor: 5.153

Review 2.  Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies.

Authors:  Nicola J Hewitt; María José Gómez Lechón; J Brian Houston; David Hallifax; Hayley S Brown; Patrick Maurel; J Gerald Kenna; Lena Gustavsson; Christina Lohmann; Christian Skonberg; Andre Guillouzo; Gregor Tuschl; Albert P Li; Edward LeCluyse; Geny M M Groothuis; Jan G Hengstler
Journal:  Drug Metab Rev       Date:  2007       Impact factor: 4.518

3.  A testing strategy to predict risk for drug-induced liver injury in humans using high-content screen assays and the 'rule-of-two' model.

Authors:  Minjun Chen; Chun-Wei Tung; Qiang Shi; Lei Guo; Leming Shi; Hong Fang; Jürgen Borlak; Weida Tong
Journal:  Arch Toxicol       Date:  2014-06-11       Impact factor: 5.153

4.  Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation.

Authors:  Vaibhav Shinde; Stefanie Klima; Perumal Srinivasan Sureshkumar; Kesavan Meganathan; Smita Jagtap; Eugen Rempel; Jörg Rahnenführer; Jan Georg Hengstler; Tanja Waldmann; Jürgen Hescheler; Marcel Leist; Agapios Sachinidis
Journal:  J Vis Exp       Date:  2015-06-17       Impact factor: 1.355

5.  High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.

Authors:  P J O'Brien; W Irwin; D Diaz; E Howard-Cofield; C M Krejsa; M R Slaughter; B Gao; N Kaludercic; A Angeline; P Bernardi; P Brain; C Hougham
Journal:  Arch Toxicol       Date:  2006-04-06       Impact factor: 5.153

6.  3D spherical microtissues and microfluidic technology for multi-tissue experiments and analysis.

Authors:  Jin-Young Kim; David A Fluri; Rosemarie Marchan; Kurt Boonen; Soumyaranjan Mohanty; Prateek Singh; Seddik Hammad; Bart Landuyt; Jan G Hengstler; Jens M Kelm; Andreas Hierlemann; Olivier Frey
Journal:  J Biotechnol       Date:  2015-01-12       Impact factor: 3.307

7.  Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor beta-induced apoptosis.

Authors:  Patricio Godoy; Jan G Hengstler; Iryna Ilkavets; Christoph Meyer; Anastasia Bachmann; Alexandra Müller; Gregor Tuschl; Stefan O Mueller; Steven Dooley
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

8.  Mechanisms of amiodarone and valproic acid induced liver steatosis in mouse in vivo act as a template for other hepatotoxicity models.

Authors:  Alexa P Vitins; Anne S Kienhuis; Ewoud N Speksnijder; Marianne Roodbergen; Mirjam Luijten; Leo T M van der Ven
Journal:  Arch Toxicol       Date:  2014-02-18       Impact factor: 5.153

9.  Hepatotoxicity of 3,4-methylenedioxyamphetamine and alpha-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates.

Authors:  Márcia Carvalho; Nuno Milhazes; Fernando Remião; Fernanda Borges; Eduarda Fernandes; Francisco Amado; Terrence J Monks; Félix Carvalho; Maria Lourdes Bastos
Journal:  Arch Toxicol       Date:  2003-10-28       Impact factor: 5.153

10.  The body-on-a-chip concept: possibilities and limitations.

Authors:  Raymond Reif
Journal:  EXCLI J       Date:  2014-12-15       Impact factor: 4.068

View more
  3 in total

1.  Pathophysiology of cholestatic liver disease and its relevance for in vitro tests of hepatotoxicity.

Authors:  Regina Stöber
Journal:  EXCLI J       Date:  2016-12-23       Impact factor: 4.068

2.  Highlight report: Monitoring cytochrome P450 activities in living hepatocytes.

Authors:  Ahmed Ghallab
Journal:  EXCLI J       Date:  2017-12-22       Impact factor: 4.068

3.  Highlight report: Metabolomics in hepatotoxicity testing.

Authors:  Ahmed Ghallab
Journal:  EXCLI J       Date:  2017-12-21       Impact factor: 4.068

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.